A Review of Outcomes for Stage Ta Bladder Tumors.

OBJECTIVES Using data from former reports, this study reviews and analyzes the outcomes of tumor recurrence, tumor progression, and tumor-specific survival of patients with stage Ta bladder tumors. METHODS Data were collected from 19 longitudinal studies of outcomes after the first diagnosis of tumor and collected as individual patient results, that is, as failure times from the first tumor to any of the three outcomes. Altogether, there were 14,252 patients, including 4,050 for the outcome of tumor recurrence, 2,937 for the outcome of tumor progression, and 11,595 for the outcome of disease-specific survival (some patients were available for more than one outcome). RESULTS In these data, the mean time to additional tumors was 7.8 years, the mean time to an invasive tumor was 19.5 years, and the mean tumor-specific survival time was 27.2 years. All three outcomes were significantly related to the 2004 World Health Organization (WHO) tumor grades. CONCLUSIONS Although greater than 50% of those with stage Ta bladder tumors have additional bladder tumors, approximately 80% appear to follow a benign course without developing invasive tumors or dying of bladder cancer. The 2004 WHO grading scheme accounts for some but not all of the prognostic information.

[1]  M. Babjuk,et al.  Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from , 2016, European urology.

[2]  J. Cheville,et al.  Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer , 2015, Modern Pathology.

[3]  S. Albisinni,et al.  Long-term experience with early single Mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: prospective, single-centre randomised trial , 2011, World Journal of Urology.

[4]  Samay Jain,et al.  Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. , 2010, Urology.

[5]  Chin-Chen Pan,et al.  Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. , 2010, American journal of clinical pathology.

[6]  B. Norlén,et al.  Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up. , 2010, Scandinavian journal of urology and nephrology.

[7]  T. H. van der Kwast,et al.  Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. , 2008, European urology.

[8]  C. Marsit,et al.  Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems. , 2007, The Journal of urology.

[9]  K. Grigor,et al.  Pattern of recurrence changes in noninvasive bladder tumors observed during 2 decades. , 2007, The Journal of urology.

[10]  M. Crundwell.  Pathology and genetics of tumours of the urinary system and male genital organs , 2004 .

[11]  A. Leong,et al.  Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. , 2004, American journal of clinical pathology.

[12]  H. Samaratunga,et al.  Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. , 2002, Urology.

[13]  David G. Bostwick,et al.  Urothelial papillary (exophytic) neoplasms , 2002, Virchows Archiv.

[14]  A. Formiconi,et al.  Biologic Differences Between Noninvasive Papillary Urothelial Neoplasms of Low Malignant Potential and Low-Grade (Grade 1) Papillary Carcinomas of the Bladder , 2001, The American journal of surgical pathology.

[15]  C. Busch,et al.  Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. , 2001, The Journal of urology.

[16]  A. Smeets,et al.  MIB‐1 as a proliferative marker in transitional cell carcinoma of the bladder , 2000, Cancer.

[17]  F Bénard,et al.  Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder. , 1999, The Journal of urology.

[18]  D. Bostwick,et al.  Papillary urothelial neoplasms of low malignant potential , 1999, Cancer.

[19]  W. Murphy.  Bladder cancer redefined , 1999, Cancer.

[20]  A. Stewart,et al.  The National Cancer Data Base report on bladder carcinoma , 1996, Cancer.

[21]  L. Chang,et al.  The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder. , 1996, British journal of urology.

[22]  L. Kiemeney,et al.  The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group. , 1994, British journal of urology.

[23]  J. Eble,et al.  Benign and low-grade papillary lesions of the urinary bladder: a review of the papilloma-papillary carcinoma controversy, and a report of five typical papillomas. , 1989, Seminars in diagnostic pathology.

[24]  L S Freedman,et al.  Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). , 1989, The Journal of urology.

[25]  W. Murphy,et al.  Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? , 1987, Cancer.

[26]  S. Loening,et al.  Superficial bladder cancer: progression and recurrence. , 1983, The Journal of urology.

[27]  W Lutzeyer,et al.  Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. , 1982, The Journal of urology.

[28]  S. Johansson,et al.  The significance of lamina propria invasion on the prognosis of patients with bladder tumors. , 1980, The Journal of urology.

[29]  J. Palou,et al.  Multivariate analysis of the prognostic factors of primary superficial bladder cancer. , 2000, The Journal of urology.

[30]  H. Herr,et al.  Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. , 2000, The Journal of urology.